0001209191-20-064259.txt : 20201217 0001209191-20-064259.hdr.sgml : 20201217 20201217204544 ACCESSION NUMBER: 0001209191-20-064259 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201215 FILED AS OF DATE: 20201217 DATE AS OF CHANGE: 20201217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZNM Capital Management, LLC CENTRAL INDEX KEY: 0001836103 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 201397749 BUSINESS ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 415-840-7337 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stead Kiersten CENTRAL INDEX KEY: 0001836117 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 201397750 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ocko Matthew CENTRAL INDEX KEY: 0001836089 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 201397751 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JNK Capital Management, LLC CENTRAL INDEX KEY: 0001836273 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 201397752 BUSINESS ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 415-840-7337 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DCVC Bio GP, LLC CENTRAL INDEX KEY: 0001735070 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 201397753 BUSINESS ADDRESS: STREET 1: 317 UNIVERSITY AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 415-840-7337 MAIL ADDRESS: STREET 1: 317 UNIVERSITY AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bogue Zachary CENTRAL INDEX KEY: 0001836157 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 201397754 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DCVC Bio, L.P. CENTRAL INDEX KEY: 0001735069 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 201397755 BUSINESS ADDRESS: STREET 1: 317 UNIVERSITY AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 415-840-7337 MAIL ADDRESS: STREET 1: 317 UNIVERSITY AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbCellera Biologics Inc. CENTRAL INDEX KEY: 0001703057 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 BUSINESS PHONE: (604) 559-9005 MAIL ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-15 0 0001703057 AbCellera Biologics Inc. ABCL 0001735069 DCVC Bio, L.P. 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001836157 Bogue Zachary 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001735070 DCVC Bio GP, LLC 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001836273 JNK Capital Management, LLC 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001836089 Ocko Matthew 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001836117 Stead Kiersten 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 0001836103 ZNM Capital Management, LLC 270 UNIVERSITY AVENUE PALO ALTO CA 94301 0 0 1 0 Common Shares 2020-12-15 4 C 0 29076350 A 29076350 I See footnote Common Shares 2020-12-15 4 C 0 29411 A 29105761 I See footnote Series A1 Preferred Shares 2020-12-15 4 C 0 2105264 0.00 D Common Shares 21052640 0 I See footnote Series A2 Preferred Shares 2020-12-15 4 C 0 802371 0.00 D Common Shares 8023710 0 I See footnote Convertible Note 17.00 2020-12-15 4 C 0 500000.00 0.00 D Common Shares 29411 0 I See footnote The Series A1 Preferred Shares and Series A2 Preferred Shares (collectively, the "Preferred Shares") were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering ("IPO"). The Preferred Shares converted into Common Shares at a 1:10 ratio upon the closing of the IPO without payment of additional consideration. The Preferred Shares had no expiration date. These securities are held by DCVC Bio, L.P. ("DCVC Bio"). DCVC Bio GP, LLC ("DCVC Bio GP") is the general partner of DCVC Bio and has sole voting and dispositive power with regard to the securities held by DCVC Bio. JNK Capital Management, LLC ("JNK") and ZNM Capital Management, LLC ("ZNM") are the managing members of DCVC Bio GP and share voting and dispositive power with respect to the securities held by DCVC Bio. The managing members of JNK and ZNM are Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead. Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead share voting and dispositive power with respect to the securities held by DCVC Bio. (Continued from Footnote 2) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that it is the beneficial owner of such securities, except to the extent of its indirect pecuniary interest therein, if any. The convertible promissory note ("Convertible Note") had a maturity date of October 30, 2025 and the principal amount of the Convertible Note converted upon the closing of the IPO into Common Shares at a conversion price equal to $17.00 per Common Share. This is one of two Form 4s filed on the date hereof in respect of these securities. The Reporting Person for the other Form 4 is John Hamer. DCVC Bio, L.P. By: DCVC Bio GP, LLC Its: General Partner By: ZNM Capital Management, LLC Its: Managing Member By: /s/ Matthew Ocko Matthew Ocko, Managing Member 2020-12-17 Zachary Bogue /s/ Zachary Bogue 2020-12-17 DCVC Bio GP, LLC, By: ZNM Capital Management, LLC Its: Managing Member By: /s/ Matthew Ocko Matthew Ocko, Managing Member 2020-12-17 JNK Capital Management, LLC, By: /s/ Kiersten Stead Kiersten Stead, Managing Member 2020-12-17 Matthew Ocko /s/ Matthew Ocko 2020-12-17 Kiersten Stead /s/ Kiersten Stead 2020-12-17 ZNM Capital Management, LLC, By: /s/ Matthew Ocko Matthew Ocko, Managing Member 2020-12-17